Protalix BioTherapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PLX Company Description
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
PLX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PLX Smart Score
Score Breakdown
PLX Company Description
Show More
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PLX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PLX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on PLX's company Twitter account
WallStreetBets
Number of mentions of PLX in WallStreetBets Daily Discussion
PLX News
Recent insights relating to PLX
CNBC Recommendations
Recent picks made for PLX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PLX
Corporate Flights
Flights by private jets registered to PLX
Our Analysis